Overexpression of FZD1 is Associated with a Good Prognosis and Resistance of Sunitinib in Clear Cell Renal Cell Carcinoma.

Peng, Qiang; Wang, Lu; Zhao, Danfeng; Lv, Yulin; Wang, Hongzhi; Chen, Guang; Wang, Jiaqi; Xu, Wanhai

Peng, Qiang; Wang, Lu; Zhao, Danfeng; Lv, Yulin; Wang, Hongzhi; Chen, Guang; Wang, Jiaqi; Xu, Wanhai.

Afiliação

Peng Q; Department of Urology, the Fourth Hospital of Harbin Medical University, Harbin Medical University, Harbin, P. R. China.
Wang L; Heilongjiang Key Laboratory of Scientific Research in Urology, Harbin, P. R. China.
Zhao D; Department of Urology, the Fourth Hospital of Harbin Medical University, Harbin Medical University, Harbin, P. R. China.
Lv Y; Heilongjiang Key Laboratory of Scientific Research in Urology, Harbin, P. R. China.
Wang H; Department of Urology, the Fourth Hospital of Harbin Medical University, Harbin Medical University, Harbin, P. R. China.
Chen G; Heilongjiang Key Laboratory of Scientific Research in Urology, Harbin, P. R. China.
Wang J; Department of Urology, the Fourth Hospital of Harbin Medical University, Harbin Medical University, Harbin, P. R. China.
Xu W; Department of Urology, the Fourth Hospital of Harbin Medical University, Harbin Medical University, Harbin, P. R. China.

J Cancer ; 10(5): 1237-1251, 2019.

Article em En | MEDLINE | ID: mdl-30854133

Palavras-chave

FZD1; clear cell renal cell carcinoma; drug-resistance; papillary renal cell carcinoma; prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Cancer Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google